T1	p 237 250	valve surgery
T2	p 652 826	90 patients who had aortic , mitral , and/or tricuspid valve replacement with Sorin Bicarbon or CarboMedics bileaflet prostheses . Fifty percent of the patients in each group
T3	i 44 64	bileaflet prostheses
T4	i 87 133	intraoperative valve orientation . Fluoroscopy
T5	i 292 302	prosthesis
T6	i 505 522	valve orientation
T7	i 575 587	fluoroscopic
T8	i 602 624	bileaflet prostheses .
T9	i 707 712	valve
T10	i 730 782	Sorin Bicarbon or CarboMedics bileaflet prostheses .
T11	i 861 883	prostheses oriented in
T12	i 886 899	perpendicular
T13	i 914 922	position
T14	i 955 963	septum .
T15	i 1646 1678	Prosthesis orientation crucially
T16	o 319 329	limitation
T17	o 337 376	technique accounting for unsatisfactory
T18	o 533 544	feasibility
T19	o 1089 1112	hemodynamic performance
T20	o 1163 1186	fluoroscopic evaluation
T21	o 1588 1611	hemodynamic performance
T22	o 1691 1706	rate of success
T23	o 1714 1739	fluoroscopic evaluation .
T24	o 1820 1858	postoperative feasibility and accuracy
T25	o 1862 1873	fluoroscopy